Reuters logo
BRIEF-Nabriva Therapeutics announces pricing of public offering of ordinary shares of nearly $80 mln
September 20, 2017 / 12:59 AM / a month ago

BRIEF-Nabriva Therapeutics announces pricing of public offering of ordinary shares of nearly $80 mln

Sept 19 (Reuters) - Nabriva Therapeutics Plc

* Nabriva Therapeutics announces pricing of public offering of ordinary shares of approximately $80 million

* Priced underwritten public offering of 9,411,765 ordinary shares at a public offering price of $8.50 per share Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below